Does DABRAFENIB Cause Non-small cell lung cancer? 79 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 79 reports of Non-small cell lung cancer have been filed in association with DABRAFENIB (Tafinlar). This represents 0.4% of all adverse event reports for DABRAFENIB.
79
Reports of Non-small cell lung cancer with DABRAFENIB
0.4%
of all DABRAFENIB reports
31
Deaths
29
Hospitalizations
How Dangerous Is Non-small cell lung cancer From DABRAFENIB?
Of the 79 reports, 31 (39.2%) resulted in death, 29 (36.7%) required hospitalization, and 2 (2.5%) were considered life-threatening.
Is Non-small cell lung cancer Listed in the Official Label?
Yes, Non-small cell lung cancer is listed as a known adverse reaction in the official FDA drug label for DABRAFENIB.
What Other Side Effects Does DABRAFENIB Cause?
Pyrexia (3,788)
Death (2,740)
Malignant neoplasm progression (1,667)
Fatigue (1,328)
Nausea (1,300)
Chills (1,235)
Rash (1,078)
Vomiting (907)
Diarrhoea (901)
Headache (697)
What Other Drugs Cause Non-small cell lung cancer?
SOTORASIB (483)
CARBOPLATIN (431)
BRIGATINIB (370)
NIVOLUMAB (366)
PACLITAXEL (275)
IPILIMUMAB (273)
PEMETREXED (234)
CERITINIB (183)
CRIZOTINIB (178)
AMG-510 (134)
Which DABRAFENIB Alternatives Have Lower Non-small cell lung cancer Risk?
DABRAFENIB vs DABRAFENIB\TRAMETINIB
DABRAFENIB vs DACARBAZINE
DABRAFENIB vs DACLATASVIR
DABRAFENIB vs DACLIZUMAB
DABRAFENIB vs DACOMITINIB